Marc Spilker is a successful American investor, business leader, and philanthropist with notable business achievements across a range of industries and interests in an array of social causes.
Spilker is a founder of GPS Investment Partners LLC, where partners invest their capital in public securities, private investments and new businesses. He also serves as chairman of Chiron Investment Management LLC, a boutique investment management firm, and is an Executive Chairman of Merchant Investment Management.
From 2010 to 2014 Spilker was president of Apollo Global Management and a member of the firm’s executive committee. Prior to joining Apollo, he had a 20-year career at Goldman Sachs where he served as co-head of the Investment Management Division (IMD) and was also a member of the firmwide management and risk committees.
Spilker’s philanthropic pursuits include support for educational institutions in New York City and beyond, public health institutes and cancer research, and Jewish causes primarily through the Marc & Diane Spilker Foundation which he and his wife established in 1996.
He is a committed supporter of independent public affairs documentaries and has provided funding for three PBS specials, all of which received critical acclaim and numerous awards. These films include Anti-Semitism in the 21st Century: The Resurgence (PBS 2007), Jerusalem: Center of the World (PBS, 2009), and The Jewish Journey: America (PBS, 2015). Spilker also supported an independently produced documentary short about the life of pianist Byron Janis and a five-part media series for The New 42nd Street, Inc.
In 2016, he received the Wharton Alumni Award for Distinguished Service and in 2010 he was honored with the Robert F. Kennedy Ripple of Hope Award which celebrates leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to social change.
A graduate of the Wharton School of the University of Pennsylvania, Spilker serves as a board member of the University of Pennsylvania’s Wharton Undergraduate Executive Board, as well as on the boards of iSentium, LLC, Maxim Capital Group, LLC and The New 42nd Street, Inc., The Samuel Bronfman Department of Medicine Advisory Board at Mount Sinai School of Medicine and the Advisory Board for Mount Sinai’s Institute for Genomics and Multiscale Biology. He was also recently named to AdvisoryAssist’s new Advisory Board. Additionally, he serves on the Third Way Board of Trustees, where he is the founder of Third Way’s Capital Markets Initiative, he is a member of the Social Finance, Inc. Advisory Council and chairs the RFK Leadership Council at the Robert F. Kennedy Center for Justice and Human Rights.